Assessing Equity in Quality Care for Metastatic Pancreatic Cancer

Authors:
George Molina Department of Surgery, Brigham and Women’s Hospital, Boston, MA
Harvard Medical School, Boston, MA

Search for other papers by George Molina in
Current site
Google Scholar
PubMed
Close
 MD, MPH
and
Jason S. Gold Department of Surgery, Brigham and Women’s Hospital, Boston, MA
Harvard Medical School, Boston, MA
Surgical Service, VA Boston Healthcare System, West Roxbury, MA

Search for other papers by Jason S. Gold in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Disclosures: The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.

Correspondence: Jason S. Gold, MD, Surgery Service, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132. Email: jgold@bwh.harvard.edu
  • Collapse
  • Expand
  • 1.

    Quote Investigator. Quote Origin: Of All the Forms of Inequality, Injustice in Health Is the Most Shocking and Inhuman. Accessed March 3, 2025. Available at: http://quoteinvestigator.com/2015/10/22/mlk-health/

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Tsilimigras DI, Woldesenbet S, Watterman B, et al. Quality score among patients with metastatic pancreatic adenocarcinoma: trends, racial disparities and impact on outcomes. J Natl Compr Canc Netw 2025;23:e247089.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Joyce DD, Shan Y, Stewart CA, et al. A SEER-Medicare based quality score for patients with metastatic upper tract urothelial carcinoma. Clin Genitourin Cancer 2024;22:1422.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Khan H, Cherla D, Mehari K, et al. Palliative therapies in metastatic pancreatic cancer: does Medicaid expansion make a difference? Ann Surg Oncol 2023;30:179188.

  • 5.

    Saadat LV, Chou JF, Gonen M, et al. Treatment patterns and survival in patients with early-onset pancreatic cancer. Cancer 2021;127:35663578.

  • 6.

    Hamad A, DePuccio M, Reames BN, et al. Disparities in stage-specific guideline-concordant cancer-directed treatment for patients with pancreatic adenocarcinoma. J Gastrointest Surg 2021;25:28892901.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Nipp R, Tramontano AC, Kong CY, et al. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med 2018;7:525535.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Patel VR, Liu M, Snyder RA, et al. Trends in racial and ethnic differences in declined surgery for resectable malignancies in the United States. Ann Surg. Published online September 3, 2024. doi:10.1097/SLA.0000000000006516.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Poulson MR, Papageorge MV, LaRaja AS, et al. Socioeconomic mediation of racial segregation in pancreatic cancer treatment and outcome disparities. Ann Surg 2023;278:246252.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Flanagan BE, Gregory EW, Hallisey EJ, et al. A social vulnerability index for disaster management. J Homel Secur Emerg Manag 2011;8.

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 5933 5933 5933
PDF Downloads 353 353 353
EPUB Downloads 0 0 0